ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 101 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,408,744 | -38.0% | 205,656 | -6.2% | 0.05% | -39.0% |
| Q2 2023 | $2,272,471 | -29.0% | 219,139 | +23.3% | 0.08% | -48.8% |
| Q3 2021 | $3,199,000 | +366.3% | 177,740 | +354.7% | 0.16% | +492.6% |
| Q2 2021 | $686,000 | -88.0% | 39,089 | -82.8% | 0.03% | -85.3% |
| Q1 2021 | $5,718,000 | +865.9% | 226,887 | +148.3% | 0.18% | +513.3% |
| Q4 2020 | $592,000 | -41.9% | 91,376 | -77.0% | 0.03% | -56.5% |
| Q3 2020 | $1,019,000 | -38.4% | 396,500 | +550.3% | 0.07% | -23.3% |
| Q2 2017 | $1,654,000 | +13.5% | 60,975 | +24.8% | 0.09% | +25.0% |
| Q1 2017 | $1,457,000 | +27.2% | 48,875 | +15.9% | 0.07% | -5.3% |
| Q4 2016 | $1,145,000 | – | 42,173 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,858,569 | $85,243,000 | 25.08% |
| Sofinnova Management VIII, L.L.C. | 1,539,480 | $45,907,000 | 24.21% |
| EcoR1 Capital, LLC | 673,100 | $20,072,000 | 5.07% |
| Cormorant Asset Management, LP | 800,000 | $23,856,000 | 3.46% |
| Perceptive Advisors | 1,260,847 | $37,598,000 | 2.14% |
| NEXTHERA CAPITAL LP | 111,500 | $3,325,000 | 1.70% |
| Foresite Capital Management III, LLC | 140,000 | $4,175,000 | 1.60% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $5,964,000 | 1.41% |
| Rock Springs Capital Management LP | 675,000 | $20,129,000 | 1.16% |
| CAXTON CORP | 13,263 | $395,000 | 1.13% |